Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2024

MissionIRNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Pioneering Green-Energy Transformation on the Water

Posted on January 31, 2024 by MissionIR

Vision Marine Technologies Inc. (NASDAQ: VMAR) is a global leader and innovator within the electric recreational boating industry. The company is pioneering clean-energy transition on the water, selling 100% electric boats, outboard motors and technology in the marine industry. “Vision … Continue reading →

Posted in Vision Marine Technologies Inc. VMAR | Leave a comment

Diamond Lake Minerals Inc. (DLMI) Serves As ‘Missing Link’ to Help Traditional Investors Enter Evolving Digital Asset Sector

Posted on January 31, 2024 by MissionIR

Multi-strategy operating company Diamond Lake Minerals (OTC: DLMI) is helping investors navigate the perceived complexities of adding digital assets to their portfolios by providing a more safe and simple gateway. Security tokens, registered with the U.S. Securities and Exchange Commission … Continue reading →

Posted in Diamond Lake Minerals Inc. DLMI | Leave a comment

SuperCom Ltd.’s (NASDAQ: SPCB) PureProtect(TM) Domestic Violence Monitoring Solution is Designed to Help Prevent Tragic Outcomes and Associated Litigation

Posted on January 31, 2024 by MissionIR

On June 30, 2015, about 25 hours after the Chicago Police Department (“CPD”) had responded to a domestic violence call at a West Side, Chicago, apartment, Vanessa Taylor was allegedly killed by her boyfriend, James Thomas. The death led to … Continue reading →

Posted in SuperCom Ltd. SPCB | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) Announces Successful Completion of SOC 2 Type 2 Audit to Further Commitment to Data Security

Posted on January 31, 2024 by MissionIR

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the world’s first commercial supplier of quantum computers, recently announced the successful completion of its SOC 2(R) Type 2 audit on December 7, 2023. This compliance … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Expands Sales Dominican Republic, Caribbean Markets with Grupo Cavel Order

Posted on January 30, 2024 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has received a vehicle order from Grupo Cavel for the sale of EVs its Electric Motors dealerships located in the Dominican Republic and Caribbean. The order was for 20 CAMPUS … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Submission of IND for Planned Phase 1b Hypertension Trial

Posted on January 30, 2024 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has submitted its much-anticipated Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”). The application covers HYPER-H23-1, the company’s upcoming planned U.S. phase 1b hypertension … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases Information on $4M Public Offering Pricing

Posted on January 30, 2024 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, announced the pricing of its public offering. According to the announcement, the “reasonable best … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

Clene Inc. (NASDAQ: CLNN) Unites Physics, Chemistry, Material Science, and Biology to Address Neurodegenerative Diseases With The Company’s Unique CNM-Au8(R) Pipeline

Posted on January 30, 2024 by MissionIR

Clene (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”), Parkinson’s disease, and multiple sclerosis (“MS”). The company’s lead drug candidate is CNM-Au8, … Continue reading →

Posted in Clene Inc. CLNN | Leave a comment

MissionIRNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Inks Grain-Management Distribution Agreement with Poppe Enterprises

Posted on January 29, 2024 by MissionIR

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal-pest populations, has entered a signed distribution agreement with Poppe Enterprises LLC. A distributor and pest-management company focused on the grain-management market, Poppe Enterprises serves Nebraska, South Dakota, North Dakota, Kansas, Wyoming, Iowa … Continue reading →

Posted in SenesTech Inc. SNES | Leave a comment

MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Class 3 EV Truck Receives CARB Certification

Posted on January 29, 2024 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has reached a commercial electric-vehicle milestone: its all-electric Class 3 low cab forward chassis truck has received certification from the California Air Resources Board (“CARB”), which means the vehicle meets specific emissions … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment